Kevin Berth

Kevin Berth has over 17 years of experience in the clinical operations field. Kevin currently holds the position of Senior Director of Clinical Operations at Capricor Therapeutics, Inc., starting in March 2023. Prior to this, from June 2021 to March 2023, they worked at Celularity Inc. as the Director of Clinical Operations.

From 2019 to 2021, Kevin served as the Director of Clinical Operations at Soligenix, Inc. Before that, they worked at Ocugen as the Director of Clinical Operations, leading clinical studies and managing the department. Kevin'sachievements in this role include successfully conducting a Phase II proof of concept study in Dry Eye and securing funding for Phase III trials. Kevin also served as the Associate Director of Clinical Operations at Ocugen from September 2017 to May 2019.

Earlier in their career, Kevin worked as the Senior Manager of Clinical Development at Ophthotech, where they were responsible for the execution of global clinical trials and managed in-house clinical research associates. Kevin also mentored junior managers in this role. Prior to that, Kevin worked at Trial Runners as a Clinical Project Manager.

From 2008 to 2012, Kevin held the position of Clinical Trial Operations Manager at Actelion. Kevin'sresponsibilities included overseeing protocol execution globally, interacting with regional operations teams, and managing vendor selection and management. Kevin also provided mentoring and guidance to the regional team.

Kevin started their career at Meda, where they worked as a Senior Clinical Research Associate (CRA) from 2005 to 2008. In this role, they managed CROs, developed protocols, and assisted with regulatory submissions. Kevin began their clinical operations career at Eyetech Pharmaceuticals as a Visual Acuity Coordinator and CRA, handling various responsibilities such as data review, budget development, and tracking potential investigators.

Overall, Kevin Berth has a diverse background in clinical operations, with experience in managing clinical studies, leading teams, and securing funding for research programs.

Kevin Berth attended Stockton University from 1998 to 2003, where they obtained a Bachelor of Science (BS) degree in Biochemistry and Molecular Biology.